Citation Impact

Citing Papers

Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
2002
Hallmarks of Cancer: The Next Generation
2011 Standout
Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor α Expression Reversing Invasive Phenotype of Breast Cancer Cells
2007
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
A soy supplement and tamoxifen inhibit sexual behavior in female rats
2004
Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment
2003
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Angiogenesis in ovarian follicular and luteal development
2000
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
1995
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Endocrine Disruptors: Can Biological Effects and Environmental Risks Be Predicted?
2002
Immunogenic cell death in cancer and infectious disease
2016 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites
1998 StandoutNobel
Neonatal exposure to diethylstilbestrol permanently alters the basal and 17β-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex
1997
Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase
1999
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Levels of Hypoxia-Inducible Factor-1  During Breast Carcinogenesis
2001 StandoutNobel
Polyphenols: food sources and bioavailability
2004 Standout
The Clinical Importance of the Metabolite Equol—A Clue to the Effectiveness of Soy and Its Isoflavones
2002
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Eicosanoids and cancer
2010 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Similarities and distinctions in the mode of action of different classes of antioestrogens.
2000
The biology of infertility: research advances and clinical challenges
2008
Endometriosis
2004 Standout
Electrostatic Basis for Bioenergetics
2004 StandoutNobel
Genistein exerts estrogen-like effects in male mouse reproductive tract
1998
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors
1997
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Cellular senescence: from physiology to pathology
2014 Standout
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
1999
Programmed Cell Death in Animal Development and Disease
2011
Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Perspective on Diabatic Models of Chemical Reactivity as Illustrated by the Gas-Phase SN2 Reaction of Acetate Ion with 1,2-Dichloroethane
2009
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Stability and Performance of Xanthobacter autotrophicus GJ10 during 1,2-Dichloroethane Biodegradation
2006
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells.
2003
The coregulator exchange in transcriptional functions of nuclear receptors
2000 Standout
Estrogen upregulates renal angiotensin II AT2receptors
2002
Histone Acetyltransferases
2001 Standout
Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia
2000
Implicit Solvation Models:  Equilibria, Structure, Spectra, and Dynamics
1999 Standout
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
2000
Tumour vasculature as a target for anticancer therapy
2000
Cumulative Dietary Energy Intake Determines the Onset of Puberty in Female Rats
2004
Mechanisms of Estrogen Action
2001 Standout
Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins
1999
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.
2003
On the Dehalogenation Mechanism of 4-Chlorobenzoyl CoA by 4-Chlorobenzoyl CoA Dehalogenase:  Insights from Study Based on the Nonenzymatic Reaction
1997
Global Uterine Genomics in Vivo: Microarray Evaluation of the Estrogen Receptor α-Growth Factor Cross-Talk Mechanism
2004
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Perspective on Diabatic Models of Chemical Reactivity as Illustrated by the Gas-Phase SN2 Reaction of Acetate Ion with 1,2-Dichloroethane
2008
On Unjustifiably Misrepresenting the EVB Approach While Simultaneously Adopting It
2009 StandoutNobel
Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study
2015
Rapid screening of environmental chemicals for estrogen receptor binding capacity.
1998
Uterine oxytocin gene expression. II. Induction by exogenous steroid administration.
1994
Computer simulations of enzyme catalysis: Finding out what has been optimized by evolution
1998 StandoutNobel
Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells
2004
Molecular Cues to Implantation
2004
Resistance, resilience, and redundancy in microbial communities
2008 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND TUMOR ANGIOGENESIS ARE REGULATED BY ANDROGENS IN HORMONE RESPONSIVE HUMAN PROSTATE CARCINOMA: : EVIDENCE FOR ANDROGEN DEPENDENT DESTABILIZATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR TRANSCRIPTS
2001
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
2000
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
2016
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Angiogenesis in Endocrine Tumors
2003
n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems
2008 StandoutNobel
Non-enzymatic and enzymatic hydrolysis of alkyl halides: A haloalkane dehalogenation enzyme evolved to stabilize the gas-phase transition state of an S N 2 displacement reaction
1997
Estrogenic responses in estrogen receptor-α deficient mice reveal a distinct estrogen signaling pathway
1997
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004

Works of Lata Murthy being referenced

Cellular Pattern of C-Fos Induction by Estradiol in the Immature Rat Uterus1
1995
Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10mutations in oligozoospermic patients impair homodimerization
2006
Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
1993
Toxicity of endogenous and environmental estrogens: what is the role of elemental interactions?
1995
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
1998
A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens.
1998
Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.
1997
Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
1996
Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus.
1992
Rankless by CCL
2026